Parkinson's affects more than 1 million people in the US. Only 10 to 20% of people with Parkinson's experience symptoms ...

Body composition emerges as a key factor in brain health, according to recent research. Targeted fat reduction and muscle ...

“This gene-to-molecule research is crucial for discovery in Alzheimer’s disease. It offers fresh perspectives on how genetic risk factors, such as APOE, influence metabolism and perhaps disease ...

The early signs of Parkinson’s disease are very often disregarded or mistaken for age, stress, or other disorders ...

The progression of Parkinson's disease often requires a change of therapy. An expert explains when this should be done and ...

A Penn Medicine-led consortium of radiology and chemistry researchers across the United States will advance imaging of ...

Groundbreaking neuroscience research by an international team led by scientists at Virginia Tech's Fralin Biomedical Research ...

Simple external cues, such as lines on the floor, can help Parkinson’s patients focus their efforts and overcome the ...

Researchers at the Foundation have uncovered new insights into the complex link between dopamine and rest tremor in Parkinson ...

Centogene NV and ROPAD consortium publish data from a landmark study identifying genetic variants that may respond to ...

Bobbi Conner talks with MUSC's Dr. Vanessa Hinson about what causes Parkinson’s disease and what can be done to reduce the ...

The darlings of the weight loss and diabetes spaces, GLP-1 receptor agonists have shown promise against Alzheimer’s in recent studies—with Phase III results expected next year from Novo Nordisk.